Skip to main content
Journal cover image

QOL-20. Low-dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study.

Publication ,  Conference
Peters, K; Affronti, ML; Woodring, S; Lipp, E; Healy, P; McShwrry, F; Herndon, J; Flahiff, C; Miller, E; Freeman, M; Minchew, J; Zalutsky, B ...
Published in: Neuro-Oncology

QOL-20

Duke Scholars

Published In

Neuro-Oncology

DOI

ISSN

1522-8517

Volume

17

Issue

Suppl 5

Start / End Page

v192 / v192

Location

San Antoni, TX

Publisher

Oxford University Press (OUP)

Conference Name

20th Annual Scientific Meeting and Educations Day of the Society for Neuro-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, K., Affronti, M. L., Woodring, S., Lipp, E., Healy, P., McShwrry, F., … Friedman, H. (n.d.). QOL-20. Low-dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study. In Neuro-Oncology (Vol. 17, pp. v192–v192). San Antoni, TX: Oxford University Press (OUP). https://doi.org/10.1093/neuonc/nov230.20
Peters, Katherine, Mary L. Affronti, Sarah Woodring, Eric Lipp, Patrick Healy, Frances McShwrry, James Herndon, et al. “QOL-20. Low-dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study.” In Neuro-Oncology, 17:v192–v192. Oxford University Press (OUP), n.d. https://doi.org/10.1093/neuonc/nov230.20.
Peters K, Affronti ML, Woodring S, Lipp E, Healy P, McShwrry F, et al. QOL-20. Low-dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study. In: Neuro-Oncology. Oxford University Press (OUP); p. v192–v192.
Peters, Katherine, et al. “QOL-20. Low-dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study.Neuro-Oncology, vol. 17, no. Suppl 5, Oxford University Press (OUP), pp. v192–v192. Manual, doi:10.1093/neuonc/nov230.20.
Peters K, Affronti ML, Woodring S, Lipp E, Healy P, McShwrry F, Herndon J, Flahiff C, Miller E, Freeman M, Minchew J, Zalutsky B, Taylor B, Boulton S, Randazzo D, Desjardins A, Vlahovic G, Bigner D, Friedman H. QOL-20. Low-dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study. Neuro-Oncology. Oxford University Press (OUP); p. v192–v192.
Journal cover image

Published In

Neuro-Oncology

DOI

ISSN

1522-8517

Volume

17

Issue

Suppl 5

Start / End Page

v192 / v192

Location

San Antoni, TX

Publisher

Oxford University Press (OUP)

Conference Name

20th Annual Scientific Meeting and Educations Day of the Society for Neuro-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences